21 November 2025 : Clinical Research
Survival and Cost Analysis of Surgical Mitral Valve Replacement With Different Prostheses: A Nationwide Cohort Study in Taiwan
Yu-san Chien
CDEF 1,2*, Ching-hu Chung ABCD 2, Jiun-yi Li ADE 2,3,4
DOI: 10.12659/MSM.950020
Med Sci Monit 2025; 31:e950020
Table 1 Bioprosthesis used in this study with designated device codes in the National Health Insurance (NHI).
| Valve model | NHI device code |
|---|---|
| Medtronic Hancock II bioprosthetic heart valve (T510) | FHV02T505TM4 |
| Carpentier-Edwards S.A.V. Bioprosthesis (6650) | FHV02A2650ED |
| Medtronic Mosaic Porcine Bioprosthesis (310) | FHVD1MSPB3M4 |
| Medtronic Mosaic Bioprosthesis | FHVD1MSP5TM4 |
| Carpentier-Edwards Perimount Pericardial Bioprosthesis Mitral (6900PTFX) | FHVD169PTFED |
| Carpentier-Edwards Perimount Pericardial Bioprosthesis – Magna | FHVD13000TED |
| Carpentier-Edwards Perimount Pericardial Bioprosthesis – Magna Ease (7300TFX) | FHVD173TFXED |